Lexology March 5, 2020
Phelps Dunbar LLP

The Department of Justice (DOJ) reported that it recovered more than $3 billion in FCA settlements and judgments in its fiscal year ending September 30, 2019. Approximately $2.6 billion of these settlements and judgments related to matters involving the healthcare industry, including drug and medical device manufacturers, managed care providers, hospitals, pharmacies, hospice organizations, laboratories and physicians. This marks the tenth consecutive year the DOJ’s civil healthcare fraud settlements and judgments has exceeded the $2 billion mark. The $2.6 billion reflect only federal losses and does not include the recovery of millions of additional dollars for state Medicaid programs.

Drug Manufacturers

Pharmaceutical manufacturers lead the way with the largest recoveries by the DOJ. Two of these recoveries involved manufacturers of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Provider, RCM (Revenue Cycle Mgmt), Regulations
Responsible AI Requires a Delicate Balancing Act
DOJ Finalizes Regulations for Accessibility of State and Local Government Websites
UK Drafting AI Regulations, But Not Rushing to Introduce Them
The rise of remote patient monitoring: Ensuring accessibility
Regulators Not ‘Dazzled’ by AI Companies’ Attempts to Avoid Scrutiny

Share This Article